Allocetra: Off-The-Shelf, Universal, Macrophage Reprogramming Cell Therapies For Life-Threatening Diseases Including Solid Tumors
Time: 2:30 pm
day: Day 1 - Track B - Lunch
Details:
- Introducing Allocetra – a new modality of macrophages reprogramming into their homeostatic state for treatment of unmet medical conditions
- Presenting significant synergistic anti-cancer combination therapy effect of Allocetra and CAR-T in human cervical cancer mice model
- Discussing the transition into first in human clinical studies in peritoneal metastasis
